Results 191 to 200 of about 316,832 (296)

Sustainable Polymer Additive Manufacturing Across Scales: A Critical Review of Pallet-Scale Structural Opportunities and Membrane Feed Spacers. [PDF]

Polymers (Basel)
Bairapudi A, Kishore MV, Reddy BVS, Sastry CC, Cep R.   +4 more
europepmc   +1 more source

la qualification de l'assurance-vie

, 2015
Tainmont, Fabienne, la qualification de l'assurance vie   +1 more
core  

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Evaluation of an AI-Based Constraint-Optimization Scheduler to Optimize On-Call Schedule Equity and Reduce Administrative Burden in a Pediatric Residency: Retrospective Comparative Study. [PDF]

J Med Internet Res
Gilad D, Farbstein-Aljanati T, Kassif Lerner R, Ashkenazi M, Pessach IM.   +4 more
europepmc   +1 more source

Qualification and Re-Qualification of NDA Instruments

, 2020
openaire   +2 more sources

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Impact of the FDA roadmap and perspectives for regulatory use of new approach methodologies in Japanese pharmaceutical companies. [PDF]

NAM J
Araki T, Naraoka H, Asakawa Y, Usui T, Kakiuchi D, Kurashige S, Shinozawa T, Nakamura K, Noda T, Nishikawa S, Suzuki M.   +10 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

AI-based virtual patient interactions improve professional language proficiency in international nurses. [PDF]

GMS J Med Educ
Ullrich S, Haus JM, Lamb S, Hermandung N, Friemel T, Stolze O, Schmidt S, Demianiuk O, Werner R, Moll-Khosrawi P, Schmitz R.   +10 more
europepmc   +1 more source